19-45179774-G-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_212550.5(BLOC1S3):c.478G>T(p.Val160Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00252 in 1,543,998 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_212550.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BLOC1S3 | NM_212550.5 | c.478G>T | p.Val160Leu | missense_variant | 2/2 | ENST00000433642.3 | NP_997715.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BLOC1S3 | ENST00000433642.3 | c.478G>T | p.Val160Leu | missense_variant | 2/2 | 2 | NM_212550.5 | ENSP00000393840.1 |
Frequencies
GnomAD3 genomes AF: 0.00195 AC: 296AN: 152114Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00167 AC: 245AN: 146848Hom.: 1 AF XY: 0.00162 AC XY: 135AN XY: 83322
GnomAD4 exome AF: 0.00259 AC: 3600AN: 1391774Hom.: 7 Cov.: 31 AF XY: 0.00253 AC XY: 1742AN XY: 689776
GnomAD4 genome AF: 0.00194 AC: 296AN: 152224Hom.: 1 Cov.: 32 AF XY: 0.00203 AC XY: 151AN XY: 74426
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Oct 10, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Nov 03, 2023 | BP4, PM1 - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 21, 2021 | The c.478G>T (p.V160L) alteration is located in exon 2 (coding exon 1) of the BLOC1S3 gene. This alteration results from a G to T substitution at nucleotide position 478, causing the valine (V) at amino acid position 160 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
BLOC1S3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 08, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 20, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at